Stayble Therapeutics AB (publ) (STABL.ST)

STO Healthcare Medical - Pharmaceuticals

Stayble Therapeutics AB (publ) operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Gothenburg, AB, SE. The stock last traded at $0.20, up 0.00% on the session, giving a market capitalisation of $13.2M. Its beta of -0.45 implies it has historically moved less than the broad market.

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.

Stayble Therapeutics AB (publ) is most often compared with the following Healthcare names: